TSOI — Therapeutic Solutions International Balance Sheet
0.000.00%
- $0.01m
- $1.26m
- $0.10m
Annual balance sheet for Therapeutic Solutions International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.026 | 0.252 | 0.094 | 0.018 | 0.028 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.003 | 0.002 | 0.017 | 0.025 | 0.019 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.14 | 0.348 | 1.12 | 0.309 | 0.086 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | 0.064 | 0.318 | 0.282 | 0.5 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.311 | 0.603 | 1.72 | 3.61 | 3.29 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.35 | 2.35 | 2.5 | 2.21 | 1.9 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.35 | 2.38 | 2.52 | 2.22 | 2.17 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -2.04 | -1.78 | -0.805 | 1.38 | 1.13 |
| Total Liabilities & Shareholders' Equity | 0.311 | 0.603 | 1.72 | 3.61 | 3.29 |
| Total Common Shares Outstanding |